BSXPA.PFD (Boston Scientific) FCF Margin % : 16.58% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Boston Scientific FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Boston Scientific's Free Cash Flow for the three months ended in Sep. 2024 was $698.00 Mil. Boston Scientific's Revenue for the three months ended in Sep. 2024 was $4,209.00 Mil. Therefore, Boston Scientific's FCF Margin % for the quarter that ended in Sep. 2024 was 16.58%.

As of today, Boston Scientific's current FCF Yield % is 1.42%.

The historical rank and industry rank for Boston Scientific's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of Boston Scientific was 13.33%. The lowest was -1.81%. And the median was 10.93%.

BSXpA.PFD's FCF Margin % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: -4.42
* Ranked among companies with meaningful FCF Margin % only.

Boston Scientific FCF Margin % Historical Data

The historical data trend for Boston Scientific's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific FCF Margin % Chart

Boston Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

12.81

11.42

11.07

7.21

11.96

Boston Scientific Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															13.95	18.52	-2.10	14.20	16.58

Competitive Comparison of Boston Scientific's FCF Margin %

For the Medical Devices subindustry, Boston Scientific's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boston Scientific's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Boston Scientific's FCF Margin % falls into.

Boston Scientific FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Boston Scientific's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	1703	/	14240
	=	11.96 %

Boston Scientific's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	698	/	4209
	=	16.58 %

Boston Scientific FCF Margin % Related Terms

Thank you for viewing the detailed overview of Boston Scientific's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Boston Scientific Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (NYSE:BSXpA.PFD) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

BSX:USA BSX:Mexico 1BSX:Italy 0HOY:UK BSX:Germany BSX:Germany BSX:Germany B1SX34:Brazil BSXC:Austria

Address

300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234

Website

https://www.bostonscientific.com

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.